Lyotropic liquid crystal mesophases as transdermal delivery systems for lipophilic drugs: A comparative study

Int J Pharm. 2023 Apr 5:636:122853. doi: 10.1016/j.ijpharm.2023.122853. Epub 2023 Mar 15.

Abstract

The present work aimed to evaluate different Liquid Crystal Mesophases (LCM) as transdermal drug delivery systems (TDDS) for nifedipine (NFD), a lipophilic drug model. The formulations composed of water, Citrus sinensis essential oil (CSEO), PPG-5-CETETH-20, and Olive oil ester PEG-7 were obtained and characterized by polarized light microscopy (PLM), rheology, small-angle x-ray scattering (SAXS), Fourier transform infrared coupled with an attenuated total reflection accessory (FTIR-ATR) and in vitro assays: bioadhesion, drug release, skin permeation, and retention tests. As a result, changes in component proportions led to several transparent viscous systems with an anisotropic profile. PLM and SAXS proved the presence of lamellar (S1), hexagonal (S3), and lamellar + hexagonal (S2) LCM, and rheology showed a high viscoelasticity profile. LCMs were able to adhere to the skin, and S2 achieved higher adhesion strength. NFD (5 mg/mL) has not modified the organization of LCMs. Results also showed that S3 promoted higher permeation and retention and higher disorganization of stratum corneum lipids, which is the main permeation-enhancing mechanism. Thus, the formulations obtained can carry and improve drug delivery through the skin and are promising TDDS for lipophilic drug administration, such as NFD.

Keywords: Lyotropic liquid crystal; Nanostructured system; Pharmaceutical nanotechnology; Transdermal drug delivery system.

MeSH terms

  • Administration, Cutaneous
  • Liquid Crystals* / chemistry
  • Pharmaceutical Preparations
  • Scattering, Small Angle
  • Skin
  • X-Ray Diffraction

Substances

  • Pharmaceutical Preparations
  • N-formyl-13-dihydrocarminomycin